Published :
Tables : 43
Figures : 41
Category : Healthcare
No. of Pages : 210
Report Code : HC-1107
Stent Delivery Systems Market Introduction Stents are placed in the body to open or to give support to the organ and delivery through this stent makes a very easy way to administer a drug or correct the abnormality in the organ. Nowadays, stent delivery systems are usually designed for through-the-scope (TTS) deployment, whereas some SEMS (self-expandable metallic stents) designs are delivered over a guide wire using fluoroscopy, also referred to as over-the-wire (OTW). With OTW delivery systems, the endoscopist can also reintroduce the endoscope alongside the stent delivery system for an endoscopic view during SEMS deployment. Most systems also allow for recapture and repositioning of the SEMS until a certain “point of no return” has been reached. Stent delivery system offers precise and intuitive deployment of the stent during a medical intervention. It reduces medical errors and improves patient compliance during the stenting process. Increasing demand of delivery systems in healthcare settings led to the robust growth of the market. Along with this, growing research activities has shown delivery systems are more reliable and easy to use than traditional methods. Further, government bodies are more focused on offering sustained healthcare services to minimize the cost burden. It led to the rapid development of special delivery systems to minimize the complications and to improve the patient outcome. It indirectly led to the potential growth of the market. Further, growing technologies have fuelled the development process of delivery systems during the forecast period. North America market is expected to witness high market share in the global market due to established healthcare systems and reimbursement policies. It is followed by the European region and it accounts a significant share in the global market due to high adoption among the end user segment. Asia-Pacific region is expected to witness a high market growth rate during the forecast period. Latin America and Rest of the world market are expected to witness significant growth during the forecast period due to the increasing presence of international players. Stent Delivery Systems market players include Boston Scientific Corporation, Abbott, B. Braun Melsungen AG, Medtronic, Stryker, Biotronik, C.R. Bard and others Stent Delivery Systems Market Segmentation : By Material Type Cobalt-Chromium Delivery System Stent-on-a-wire delivery system Others By End User Hospital Ambulatory Surgical Centres Catheterization Laboratories By Region North America Latin America Europe Asia Pacific Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global Stent Delivery Systems Market by Material Type, by End-User, and by Region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Stents are placed in the body to open or to give support to the organ and delivery through this stent makes a very easy way to administer a drug or correct the abnormality in the organ. Nowadays, stent delivery systems are usually designed for through-the-scope (TTS) deployment, whereas some SEMS (self-expandable metallic stents) designs are delivered over a guide wire using fluoroscopy, also referred to as over-the-wire (OTW). With OTW delivery systems, the endoscopist can also reintroduce the endoscope alongside the stent delivery system for an endoscopic view during SEMS deployment. Most systems also allow for recapture and repositioning of the SEMS until a certain “point of no return” has been reached.
Stent delivery system offers precise and intuitive deployment of the stent during a medical intervention. It reduces medical errors and improves patient compliance during the stenting process. Increasing demand of delivery systems in healthcare settings led to the robust growth of the market. Along with this, growing research activities has shown delivery systems are more reliable and easy to use than traditional methods. Further, government bodies are more focused on offering sustained healthcare services to minimize the cost burden. It led to the rapid development of special delivery systems to minimize the complications and to improve the patient outcome. It indirectly led to the potential growth of the market. Further, growing technologies have fuelled the development process of delivery systems during the forecast period.
North America market is expected to witness high market share in the global market due to established healthcare systems and reimbursement policies. It is followed by the European region and it accounts a significant share in the global market due to high adoption among the end user segment. Asia-Pacific region is expected to witness a high market growth rate during the forecast period. Latin America and Rest of the world market are expected to witness significant growth during the forecast period due to the increasing presence of international players.
Stent Delivery Systems market players include Boston Scientific Corporation, Abbott, B. Braun Melsungen AG, Medtronic, Stryker, Biotronik, C.R. Bard and others
By Material Type
By End User
By Region
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global Stent Delivery Systems Market by Material Type, by End-User, and by Region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Stent Delivery Systems Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Stent Delivery Systems Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Stent Delivery Systems Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Stent Delivery Systems Market, By Material Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Cobalt-Chromium Delivery System 7.2. Stent-on-a-wire delivery system 7.3. Others 8. Stent Delivery Systems Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Hospital 8.2. Ambulatory Surgical Centres 8.3. Catheterization Laboratories 9. North America Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028 10. Latin America Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028 11. Europe Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028 12. Asia Pacific Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028 14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Boston Scientific Corporation 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Abbott 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. B. Braun Melsungen AG 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Medtronic 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Stryker 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Biotronik 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. C.R. Bard 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Stent Delivery Systems Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Stent Delivery Systems Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Stent Delivery Systems Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Stent Delivery Systems Market, By Material Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Cobalt-Chromium Delivery System 7.2. Stent-on-a-wire delivery system 7.3. Others
8. Stent Delivery Systems Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Hospital 8.2. Ambulatory Surgical Centres 8.3. Catheterization Laboratories
9. North America Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028
10. Latin America Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028
11. Europe Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028
12. Asia Pacific Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. Boston Scientific Corporation 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Abbott 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. B. Braun Melsungen AG 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Medtronic 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Stryker 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Biotronik 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. C.R. Bard 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview
16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics